Fig. 4.
Fig. 4. Characterization of the Lin− UCB SP for HSC properties. / (A,B) The expression of CD34 and CD38 on Lin− (A) and on Lin− SP UCB cells (B). The SP represented the dimmest 0.5% to 1.0% of the Hoechst-stained Lin− UCB cells. Quadrant statistics are provided for the individual experiment depicted. (C-F) The expression of Thy-1 (CDw90; C), HLA-DR (D), CD45RA (E), or CD71 (F) versus that of CD34 within the Lin− SP. In all panels, CD34 is depicted on the x-axis regardless of the fluorochrome used. Quadrant statistics are provided for the individual experiments depicted. Each panel is representative of at least 3 experiments. (G,H) Myelo-erythroid hematopoietic progenitors were quantified from unfractionated UCB, Lin− UCB, the Lin− SP, the CD34+Lin− SP, and the CD34−Lin− SP fractions. These were enumerated in HPCAs (G) and in 5-week LTC assays on MS5 cells (H). These data are the mean ± SD of 5 experiments. All but 2 of the HPCAs detected from CD34−Lin− SP cells were derived from cells isolated from a single sort.

Characterization of the Lin UCB SP for HSC properties.

(A,B) The expression of CD34 and CD38 on Lin (A) and on Lin SP UCB cells (B). The SP represented the dimmest 0.5% to 1.0% of the Hoechst-stained Lin UCB cells. Quadrant statistics are provided for the individual experiment depicted. (C-F) The expression of Thy-1 (CDw90; C), HLA-DR (D), CD45RA (E), or CD71 (F) versus that of CD34 within the Lin SP. In all panels, CD34 is depicted on the x-axis regardless of the fluorochrome used. Quadrant statistics are provided for the individual experiments depicted. Each panel is representative of at least 3 experiments. (G,H) Myelo-erythroid hematopoietic progenitors were quantified from unfractionated UCB, Lin UCB, the Lin SP, the CD34+Lin SP, and the CD34Lin SP fractions. These were enumerated in HPCAs (G) and in 5-week LTC assays on MS5 cells (H). These data are the mean ± SD of 5 experiments. All but 2 of the HPCAs detected from CD34Lin SP cells were derived from cells isolated from a single sort.

Close Modal

or Create an Account

Close Modal
Close Modal